KRYSTIN PRASAD: Open Payments
NPI 1477974939 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 65 payments from 11 companies in 2025. Trend: 2023 $4,855 · 2024 $989 · 2025 $1,212
Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $311 |
| ABBVIE INC. | 13 | $172 |
| Otsuka America Pharmaceutical, Inc. | 10 | $168 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $108 |
| Vanda Pharmaceuticals Inc. | 5 | $83 |
| Alkermes, Inc. | 5 | $78 |
| Almatica Pharma LLC | 5 | $76 |
| Janssen Pharmaceuticals, Inc | 3 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
Products named: Auvelity, REXULTI, VRAYLAR, CAPLYTA, TRINTELLIX, FANAPT, LOREEV XR, SPRAVATO.
Industry payments across NJ — which companies pay providers there.
